McIntyre Roger S
Department of Psychiatry and Pharmacology, University of Toronto, and the Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada.
J Clin Psychiatry. 2009 Jun;70(6):e17. doi: 10.4088/jcp.7075tx3c.
Patients with severe mental disorders have increased mortality rates compared with the general population. The leading cause of death for individuals with psychotic illnesses or bipolar disorder is cardiovascular disease (CVD), which is often the result of patients' health problems associated with their psychiatric disorders, including, but not limited to, obesity, metabolic syndrome, and diabetes. Such problems occur more often and have worse outcomes in patients with serious mental illness than the general population because of a combination of factors such as inadequate access to quality care, poor lifestyle choices, and the association between some antipsychotic medications and weight gain. Coordinated somatic and psychiatric treatment, weight-neutral or weight-reducing pharmaceuticals, and behavioral weight management programs may help lessen the burden of CVD in the mental health population.
与普通人群相比,患有严重精神障碍的患者死亡率更高。患有精神病性疾病或双相情感障碍的个体的主要死因是心血管疾病(CVD),这通常是患者与精神障碍相关的健康问题导致的结果,包括但不限于肥胖、代谢综合征和糖尿病。由于诸如获得优质护理的机会不足、不良的生活方式选择以及某些抗精神病药物与体重增加之间的关联等多种因素的综合作用,这些问题在患有严重精神疾病的患者中比普通人群更常出现且后果更严重。协调的躯体和精神治疗、体重中性或减重药物以及行为体重管理计划可能有助于减轻精神健康人群中CVD的负担。